Skip to main content
logo
DiaMedica Therapeutics logo
DiaMedica Therapeutics Inc. (DMAC)
NASDAQ: DMAC · Real-Time Price · USD
8.33
+0.32 (4.00%)
Oct 9, 2026, 4:00 PM EDT - Market closed

DiaMedica Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
4494152321084299
Market Cap Growth
24.85%78.53%115.41%157.97%-57.63%-48.10%
Enterprise Value
40635918252651
Last Close Price
8.337.965.432.841.583.73

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
11.727.395.702.111.312.24
P/TBV Ratio
11.727.395.702.111.312.24

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.010.000.010.010.020.00
Net Debt / Equity Ratio
-1.13-1.06-1.08-1.03-1.04-1.02
Net Debt / EBITDA Ratio
1.111.741.642.472.363.31
Net Debt / FCF Ratio
1.372.051.982.802.853.67
Quick Ratio
6.6411.728.2319.1215.4929.69
Current Ratio
6.7211.818.2819.2715.6129.82
Return on Equity (ROE)
-114.61%-67.68%-53.27%-46.77%-36.06%-38.81%
Return on Assets (ROA)
-64.12%-39.92%-33.18%-30.02%-21.89%-23.16%
Return on Capital Employed (ROCE)
-102.10%-61.20%-65.10%-41.40%-43.40%-31.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-8.36%-7.90%-10.53%-17.98%-32.73%-13.78%
FCF Yield
-7.02%-7.02%-9.52%-17.40%-27.74%-12.45%
Buyback Yield / Dilution
-22.41%-16.28%-24.07%-23.16%-27.29%-32.48%
SEC Filings: 10-K · 10-Q